Global Heart Hub and Novartis announced the launch of the Invisible Nation program. Invisible Nation will bring together a worldwide network of patient organizations and other stakeholders in the cardiovascular (CV) space committed to effecting systemic change in the management of atherosclerotic cardiovascular disease (ASCVD). The program aims to prevent many of the 15 million yearly ASCVD deaths(1) and reduce what could soon become $1 trillion in annual CV disease cost(2).
Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world’s #1 killer
October 20, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022